Houston clean tech startup accelerator announces 7 companies to inaugural cohort

seeing green

Two Houston-based companies made it into this new clean tech accelerator. Photo via greentownlabs.com

The Low-Carbon Hydrogen Accelerator announced its inaugural class of clean tech startups — two of which hail from right here in Hosuton.

In all, seven startups have been chosen to participate this year in the Low-Carbon Hydrogen Accelerator, which was announced in November. The six-month accelerator program offers collaboration and engagement opportunities with the Electric Power Research Institute and its member utilities, as well as with Shell. Through the accelerator, the institute and Shell will provide startups with two innovation paths: a technology validation track and a technology demonstration track.

The accelerator — part of the Green Go program, affiliated with Greentown Labs — is aimed at coming up with innovations in low-carbon hydrogen production, storage, and distribution.

“Accelerating low-carbon hydrogen technologies is an essential part of achieving global net-zero targets by 2050,” Neva Espinoza, vice president of energy supply and low-carbon resources at the Electric Power Research Institute, says in a news release.

The inaugural LCHA cohort includes:

  • Advanced Ionics, based in Milwaukee, is enabling green hydrogen production without the green premium.
  • Arco Technologies from Bologna, Italy, is developing a proprietary Anion Exchange Membrane electrolyzer with the lowest capital expenditures and operating expenses possible today.
  • Based in Manchester in the United Kingdom, Clean Power is developing a novel, low-cost, highly durable hydrogen polymer electrolyte membrane fuel cell delivering zero-emission electricity.
  • Element Resources, based in Houston, is enabling compressed hydrogen storage tank technology.
  • Another local company, Smartpipe Technologies is developing a robust self-monitored repurposed pipeline system for hydrogen with minimal environmental disruption.
  • SPEC Sensors from California is creating a robust and reliable meshed sensor network for hydrogen leak detection and line-monitoring systems.
  • Canadian company RUNWITHIT Synthetics is creating a live, digital twin modeling platform that generates decision-support data for regional hydrogen-demand scenarios.

Element Resources, which produces hydrogen from renewables for mobility, power production, and energy storage, is collaborating with Zhifeng Ren, M.D. Anderson chair professor in physics and director of the Texas Center for Superconductivity at the University of Houston.

The other Houston startup, Smartpipe Technologies, announced earlier this month that Canadian pipeline company Enbridge had made a $6.6 million investment in the startup.

For 2022, the accelerator received applications from 88 startups in 18 countries. The five other participants this year are from California; Wisconsin; Alberta, Canada; Italy; and the United Kingdom.

Aside from the Electric Power Research Institute, Shell USA, and Greentown, the accelerator’s partners are the City of Houston and the Urban Future Lab at New York University’s Tandon School of Engineering.

“Creating a robust hydrogen economy will require a systems-oriented approach and unparalleled cooperation between corporate partners and emerging companies,” says Ryan Dings, chief operating officer and general counsel at Greentown Labs.

Greentown operates startup incubators in Somerville, Massachusetts, and Houston.

A new six-month accelerator program is looking to move the needle on the energy transition. Photo via greentownlabs.com

Houston organizations team up to accelerate startups with low-carbon solutions

greentown hou

Attention, innovators: A new initiative in Houston is searching for startups whose offerings can help reduce global carbon emissions.

The Low-Carbon Hydrogen Accelerator is a partnership involving Greentown Labs, the Electric Power Research Institute, Shell Oil, the City of Houston, and New York University's Urban Future Lab. The accelerator is seeking applications from startups that are advancing low-carbon hydrogen production, enhancing hydrogen storage and distribution, or providing business models for management of hydrogen supply chains. Applications are due February 9, 2022.

"If we can improve the devices and processes that will be used to make, transport, and store clean hydrogen in the future, it can become a cost-competitive fuel. At the same time, these advances can improve the capacity factor of renewable generation, producing multiple economic and climate benefits," Pat Sapinsley, managing director of cleantech initiatives at the Urban Future Lab, says in a news release.

The six-month accelerator will enable startups to collaborate with the Electric Power Research Institute, utilities, and Shell on tech development, feasibility studies, pilot projects, and other low-carbon efforts.

The institute and Shell will provide startups two routes within the accelerate: a path for validation of their technology and a path for demonstration of their technology.

"Accelerating low-carbon hydrogen technologies is essential to achieving global net-zero targets by 2050," says Neva Espinoza, the institute's vice president of energy supply and low-carbon resources.

Shell foresees hydrogen playing a bigger role in hard-to-decarbonize sectors such as heavy-duty trucking, marine, aviation, chemicals, steel, and cement. Julie Ferland, vice president of innovation excellence at Houston-based Shell Oil, says programs such as the new accelerator will be critical to fostering low-carbon energy.

Earlier this year, after visiting Greentown Labs' Houston location, U.S. Energy Secretary Jennifer Granholm and the U.S. Department of Energy launched the Hydrogen Energy Earthshot to reduce the cost of clean hydrogen by 80 percent to $1 per kilogram by 2030.

"As the Energy Capital of the World, I believe it is our responsibility to continue Houston's legacy of energy innovation and develop the technologies and practices needed to decarbonize the global energy sector," Houston Mayor Sylvester Turner says. "Houston has the skilled workforce and infrastructure to develop clean hydrogen at scale, and Greentown Labs' Low-Carbon Hydrogen Accelerator is a great example of the kind of partnerships we need to make it happen."

Greentown Labs is the largest climatech startup incubator in North America. The Somerville, Massachusetts-based incubator recently opened its Houston location.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings